Skip to main content
Premium Trial:

Request an Annual Quote

Intelligent Bio-Systems Unveils a New Sequencing Machine


Intelligent Bio-Systems announced a new sequencing-by-synthesis instrument for targeted sequencing, called the Mini-20, at the Association of Biomolecular Resource Facilities annual meeting, held in Orlando, Fla., in March.

The Mini-20 is aimed at core and clinical labs, IBS founder and CEO Steven Gordon said, as it allows users to add samples while runs are in process. This, he added, could help users who need to run multiple samples, but do not want to wait for a full complement before beginning analysis.

The Mini-20 has a carousel-like organization, Gordon said. Inside, it houses 20 flow cells that shift to different stations for reagent delivery as well as for washing and imaging. Once the in-progress runs reach a convenient stopping point in their cycles, users can add more samples. Each flow cell is barcoded, he added, and thus its progress in the run is monitored.

The machine is priced at $120,000, and it will be available to early-access users in the second quarter of 2012. The cost to run a 10 micro-liter flow cell is estimated to be less than $150, and a single flow cell can generate 20 million reads. If all flow cells in the machine are in use, it can produce 400 million reads and 80 gigabases, Gordon said. Ten samples can be sequenced in a day.

IBS also has a Max-Seq instrument for full-genome sequencing that the company announced last year that can generate 100 gigabases of data per run.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.